Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Theurillat JP, Zürrer-Härdi U, Varga Z, Storz M, Probst-Hensch NM, Seifert B, Fehr MK, Fink D, Ferrone S, Pestalozzi B, Jungbluth AA, Chen YT, Jäger D, Knuth A, Moch H. Theurillat JP, et al. Cancer Immunol Immunother. 2007 Nov;56(11):1723-31. doi: 10.1007/s00262-007-0316-1. Epub 2007 Apr 5. Cancer Immunol Immunother. 2007. PMID: 17410359 Free PMC article.
A requirement for p120-catenin in the metastasis of invasive ductal breast cancer.
Kurley SJ, Tischler V, Bierie B, Novitskiy SV, Noske A, Varga Z, Zürrer-Härdi U, Brandt S, Carnahan RH, Cook RS, Muller WJ, Richmond A, Reynolds AB. Kurley SJ, et al. Among authors: zurrer hardi u. J Cell Sci. 2021 Mar 17;134(6):jcs250639. doi: 10.1242/jcs.250639. J Cell Sci. 2021. PMID: 33097605 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34005305
Slug and Sox9 cooperatively determine the mammary stem cell state.
Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zürrer-Härdi U, Bell G, Tam WL, Mani SA, van Oudenaarden A, Weinberg RA. Guo W, et al. Cell. 2012 Mar 2;148(5):1015-28. doi: 10.1016/j.cell.2012.02.008. Cell. 2012. PMID: 22385965 Free PMC article.
Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
Sarki M, Ming C, Aissaoui S, Bürki N, Caiata-Zufferey M, Erlanger TE, Graffeo-Galbiati R, Heinimann K, Heinzelmann-Schwarz V, Monnerat C, Probst-Hensch N, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC, On Behalf Of The Cascade Consortium. Sarki M, et al. Among authors: zurrer hardi u. Cancers (Basel). 2022 Mar 23;14(7):1636. doi: 10.3390/cancers14071636. Cancers (Basel). 2022. PMID: 35406409 Free PMC article.
Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
Kim S, Aceti M, Baroutsou V, Bürki N, Caiata-Zufferey M, Cattaneo M, Chappuis PO, Ciorba FM, Graffeo-Galbiati R, Heinzelmann-Schwarz V, Jeong J, Jung MM, Kim SW, Kim J, Lim MC, Ming C, Monnerat C, Park HS, Park SH, Pedrazzani CA, Rabaglio M, Ryu JM, Saccilotto R, Wieser S, Zürrer-Härdi U, Katapodi MC. Kim S, et al. Among authors: zurrer hardi u. JMIR Res Protoc. 2021 Jun 11;10(6):e26264. doi: 10.2196/26264. JMIR Res Protoc. 2021. PMID: 34114954 Free PMC article.
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study.
Stoffel ST, von Moos R, Thürlimann B, Cathomas R, Gillessen S, Zürrer-Härdi U, von Briel T, Anchisi S, Feller A, Schär C, Dietrich D, Schwenkglenks M, Lupatsch JE, Mark MT. Stoffel ST, et al. Among authors: zurrer hardi u. Swiss Med Wkly. 2021 Mar 1;151:w20464. doi: 10.4414/smw.2021.20464. eCollection 2021 Mar 1. Swiss Med Wkly. 2021. PMID: 33705559 Free article.
18 results